Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Nyse  >  Colfax Corporation    CFX


SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Colfax : DJO® Announces New Stemless Shoulder Offering – the AltiVate® Anatomic CS EDGE™

09/30/2020 | 09:30am EST

The data-driven design of the CS EDGE™ helps optimize implant fit while preserving bone

DJO, LLC (“DJO” or the “Company”), a leading global provider of medical technologies to get and keep people moving, today announced the launch of the canal-sparing AltiVate® Anatomic CS EDGE™ Shoulder System. As the latest innovation from shoulder industry leader DJO®, the new system is designed to provide a more bone-sparing solution that is less invasive than traditional shoulder stem offerings.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200930005578/en/

AltiVate® Anatomic CS EDGE™ (Photo: Business Wire)

AltiVate® Anatomic CS EDGE™ (Photo: Business Wire)

Around 67,000 anatomic total shoulder arthroplasty procedures are done each year in the United States, and that number is expected to grow by 8.6% over the next two years.1 Through the introduction of newer tissue-sparing technologies like short stem and stemless shoulder implants, future growth in the US shoulder arthroplasty market is expected to be driven by increasing penetration into the younger patient population.2

“Our goal is to continue to drive innovation and bring market-leading products to patients; the addition of AltiVate Anatomic CS EDGE delivers the next advancement in our shoulder solutions portfolio,” said Louis Vogt, Vice President of Sales and Marketing, DJO Surgical®. “With the growing active patient population, the CS EDGE offers a unique bone-conserving solution to surgeons to address the needs of their anatomic arthroplasty patients.”

The design of the AltiVate Anatomic CS EDGE is based off a humeral fit analysis that was conducted to help optimize fit of peripherally targeted fins within the humeral metaphysis.3 The AltiVate Anatomic CS EDGE features a canal-sparing, 3-fin humeral stem with unique serrated fin tips, allowing surgeons the option to use the implant to cut into the bone. The system also incorporates P2™, a proprietary titanium porous coating that aids in the apposition of bone for excellent in-growth performance and an enhanced press-fit implantation.4

“As the first surgeon to use the AltiVate Anatomic CS EDGE, I was impressed by the press-fit implantation offered by this system. During insertion, you can feel the exceptional primary fixation and stability the implant design offers, which is critical in stemless applications,” said Dr. T. Bradley Edwards, Fondren Orthopedic Group in Houston, TX. “The innovative design of the CS EDGE system provides the best stemless implant fixation available in today’s market. In addition, the streamlined instrumentation creates efficiency, resulting in shorter operative time compared to other traditional stem systems I’ve used.”

Compatible with the AltiVate Anatomic e+™ glenoid component featuring patented Drop-and-Go® technology for immediate fixation,5 the CS EDGE™ Shoulder System gives surgeons the cutting edge needed in anatomic total shoulder arthroplasty solutions.

“I’ve been using the AltiVate Anatomic System for years, and I’m excited about the addition of the stemless product offering. The system maintains the intuitive and easy-to-use qualities that are characteristic of the AltiVate Anatomic brand,” said Dr. Jonathan Levy, Holy Cross Orthopedic Institute in Ft. Lauderdale, FL. “The immediate fixation achieved by the CS EDGE’s novel fin design and P2™ porous coating is quite remarkable, allowing me to confidently use the implant in patients of all ages. The CS EDGE has helped me to precisely replicate anatomy, minimize bone and blood loss during surgery, and facilitate shoulder arthroplasty in the outpatient setting with an efficient surgical workflow.”

The AltiVate® Anatomic CS EDGE™ is an important addition to DJO’s industry-leading AltiVate® Extremity Solutions product portfolio. For more information about AltiVate Anatomic CS EDGE, please visit www.djoglobal.com/altivate-cs-edge


1 Smart TRAK® - Anatomic Total Shoulder Replacement Procedures, 2019

2 Smart TRAK® Shoulder Replacement https://app.smarttrak.com/markets/qs/d5ba9c8c85ec851cac1002a5f5bc1f81

3,4,5 Data on file at DJO®. Laboratory testing does not necessarily indicate clinical performance.

Dr. T. Bradley Edwards and Dr. Jonathan Levy are paid consultants for DJO®.

About DJO®

DJO, a subsidiary of Colfax Corporation (NYSE: CFX), is a leading developer and distributor of high-quality medical devices that provide proven solutions for musculoskeletal health, joint reconstruction, vascular health, and pain management. The Company’s extensive range of products and integrated technologies address the orthopedic continuum of care from performance and mobility to surgical intervention and post-operative rehabilitation; enabling people around the world to regain or maintain their natural motion. For additional information about DJO, please visit www.DJOGlobal.com.

© Business Wire 2020
03:26pCOLFAX : UBS Adjusts Price Target on Colfax to $45 From $40, Reiterates Buy Rati..
01/08INSIDER TRENDS : 90-Day Insider Selling Trend Prolonged at Colfax
2020INSIDER TRENDS : 90-Day Insider Buying Trend at Colfax Interrupted with Sale of ..
2020COLFAX : Deutsche Bank Adjusts Price Target for Colfax to $39 From $36, Maintain..
2020COLFAX : Morgan Stanley Adjusts Colfax' Price Target to $39 from $30, Keeps Equa..
2020INSIDER TRENDS : Insider Purchase Continues Colfax Positive Trend
2020COLFAX : DJO, a Subsidiary of Colfax, Acquires LiteCure Laser Therapy for Undisc..
2020COLFAX : DJO® Acquires LiteCure Laser Therapy
2020Barclays Adjusts Colfax's Price Target to $35 From $31, Keeps Equal-Weight Ra..
2020KeyBanc Adjusts Colfax's Price Target to $44 From $36, Keeps at Overweight
More news
Financials (USD)
Sales 2020 3 070 M - -
Net income 2020 48,6 M - -
Net Debt 2020 2 099 M - -
P/E ratio 2020 105x
Yield 2020 -
Capitalization 4 709 M 4 709 M -
EV / Sales 2020 2,22x
EV / Sales 2021 1,95x
Nbr of Employees 15 000
Free-Float 84,9%
Duration : Period :
Colfax Corporation Technical Analysis Chart | CFX | US1940141062 | MarketScreener
Technical analysis trends COLFAX CORPORATION
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 18
Average target price 43,50 $
Last Close Price 39,75 $
Spread / Highest target 43,4%
Spread / Average Target 9,43%
Spread / Lowest Target -11,9%
EPS Revisions
Managers and Directors
Matthew L. Trerotola President, Chief Executive Officer & Director
Mitchell P. Rales Non-Executive Chairman
Christopher Michael Hix CFO, Treasurer & Senior Vice President
Patrick William Allender Independent Director
Thomas Sinnickson Gayner Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ATLAS COPCO AB10.19%64 937
SANDVIK AB8.30%32 880